Skip to main content
. 2023 Feb 9;14:23. doi: 10.1186/s13287-022-03234-y

Table 5.

Changes of gray matter volume from baseline to month 6 in the treatment group

Baseline 6 M P value
Total volume 614,239.25 ± 39,964.24 623,498.50 ± 40,216.82 0.438
49 (SOG.L) 4924.49 ± 685.36 5164.16 ± 729.92 0.035*
52 (MOG.R) 8141.31 ± 1263.95 8737.89 ± 1148.10 0.019*
53 (IOG.L) 4474.26 ± 485.94 4860.14 ± 544.49 0.042*
54 (IOG.R) 4239.01 ± 797.49 4680.28 ± 814.30 0.023*
56 (FFG.R) 11,843.16 ± 1078.77 12,450.73 ± 960.36 0.008**
60 (SPG.R) 5877.22 ± 960.71 6482.12 ± 926.72 0.005**
62 (IPL.R) 5238.69 ± 587.67 5713.49 ± 566.96 0.007**
66 (ANG.R) 6505.39 ± 727.61 7008.39 ± 871.93 0.043*
87 (TPOmid.L) 2390.20 ± 654.50 2586.36 ± 506.35 0.031*

6 M: 6 months after treatment; SOG.L: Superior occipital gyrus; MOG.R: Middle occipital gyrus; IOG.L: Inferior occipital gyrus; IOG.R: Inferior occipital gyrus; FFG.R: Fusiform gyrus; SPG.R: Superior parietal gyrus; IPL.R: Inferior parietal, but supramarginal and angular gyri; ANG.R: Angular gyrus; TPOmid.L: Temporal pole: middle temporal gyrus

*P < 0.05; **P < 0.01